Literature DB >> 9142315

Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.

M A Nalesnik1, A S Rao, A Zeevi, J J Fung, S Pham, H Furukawa, A Gritsch, G Klein, T E Starzl.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9142315      PMCID： PMC2963039          DOI： 10.1016/s0041-1345(96)00112-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  39 in total

Review 1.  The lost chord: microchimerism and allograft survival.

Authors:  T E Starzl; A J Demetris; N Murase; M Trucco; A W Thomson; A S Rao
Journal:  Immunol Today       Date:  1996-12

2.  Primary malignancy in patients undergoing immunosuppression for renal transplantation.

Authors:  C F McKhann
Journal:  Transplantation       Date:  1969-08       Impact factor: 4.939

3.  Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease.

Authors:  D N Kenagy; Y Schlesinger; K Weck; J H Ritter; M M Gaudreault-Keener; G A Storch
Journal:  Transplantation       Date:  1995-09-27       Impact factor: 4.939

4.  Aggressive treatment for postcardiac transplant lymphoproliferation.

Authors:  L J Swinnen; G M Mullen; T J Carr; M R Costanzo; R I Fisher
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

5.  Malignant lymphomas following allogenic disease: transition from an immunological to a neoplastic disorder.

Authors:  R S Schwartz; L Beldotti
Journal:  Science       Date:  1965-09-24       Impact factor: 47.728

6.  Outcome analysis of 71 clinical intestinal transplantations.

Authors:  S Todo; J Reyes; H Furukawa; K Abu-Elmagd; R G Lee; A Tzakis; A S Rao; T E Starzl
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

7.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

Authors:  E A Walter; P D Greenberg; M J Gilbert; R J Finch; K S Watanabe; E D Thomas; S R Riddell
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

Review 8.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

9.  Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin.

Authors:  D J Weissmann; J A Ferry; N L Harris; D N Louis; F Delmonico; I Spiro
Journal:  Am J Clin Pathol       Date:  1995-06       Impact factor: 2.493

10.  Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.

Authors:  B Blazar; M Patarroyo; E Klein; G Klein
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307
View more
  1 in total

1.  Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.

Authors:  D E Tsai; E A Stadtmauer; D J Canaday; D J Vaughn
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.